185749-17-1Relevant articles and documents
20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
-
Paragraph 00117, (2017/09/27)
The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present invention display sign
New perspective for natural products synthesis: Concise synthesis of (+)-Sch 642305 by chiral auxiliary multiuse methodology
Fujioka, Hiromichi,Ohba, Yusuke,Nakahara, Kenji,Takatsuji, Mayuko,Murai, Kenichi,Ito, Motoki,Kita, Yasuyuki
, p. 5605 - 5608 (2008/09/17)
The synthesis of (+)-Sch 642305 is an example of chiral auxiliary multiuse methodology, which shows a new perspective for the synthesis of compounds with multiple asymmetric centers. Thus, (+)-Sch 642305 was concisely synthesized from the known compound.
Highly Diastereoselective Conjugate Addition of Lithiated γ-Crotonolactone (But-2-en-4-olide) to Cyclic Enones to Give Syn-Adducts: Application to a Brefeldin Synthesis
Haynes, Richard K.,Lam, William W.-L.,Yeung, Lam-Lung,Williams, Ian D.,Ridley, Andrew C.,Starling, Scott M.,Vonwiller, Simone C.,Hambley, Trevor W.,Lelandais, Patrick
, p. 4552 - 4553 (2007/10/03)
-